sQuiz your knowledge! Itchy, polymorphic skin lesions in a patient with clear cell renal carcinoma Nivolumab-induced bullous pemphigoid

被引:0
|
作者
Wojcik, Ewa [1 ]
Stefaniak, Aleksandra [1 ]
Szepietowski, Jacek C. [1 ]
机构
[1] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Ul Chalubinskiego 1, PL-50368 Wroclaw, Poland
关键词
D O I
10.1684/ejd.2020.3938
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:769 / 770
页数:2
相关论文
共 50 条
  • [41] Lymphozytäre Myokarditis unter Nivolumabtherapie bei metastasiertem klarzelligen NierenzellkarzinomLymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with Nivolumab
    R. Sauer
    P. Kiewe
    M. Desole
    M. Schuler
    F. Theissig
    A. Roth
    T. Mairinger
    Der Pathologe, 2017, 38 : 535 - 539
  • [42] Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation
    Beulque, Yana
    Deleu, Anne-Leen
    Punie, Kevin
    De Wever, Liesbeth
    Baldewijns, Marcella
    Caruso, Stefano
    Couchy, Gabrielle
    Zucman-Rossi, Jessica
    Beuselinck, Benoit
    CLINICAL GENITOURINARY CANCER, 2019, 17 (05) : E909 - E912
  • [43] Non-O1 Vibrio cholerae inguinal skin and soft tissue infection with bullous skin lesions in a patient with a penis squamous cell carcinoma
    Aguinaga, Aitziber
    Portillo, Maria E.
    Yuste, Jose R.
    del Pozo, Jose L.
    Garcia-Tutor, Emilio
    Perez-Gracia, Jose L.
    Leiva, Jose
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2009, 8
  • [44] Non-O1 Vibrio cholerae inguinal skin and soft tissue infection with bullous skin lesions in a patient with a penis squamous cell carcinoma
    Aitziber Aguinaga
    María E Portillo
    Jose R Yuste
    Jose L del Pozo
    Emilio García-Tutor
    Jose L Pérez-Gracia
    José Leiva
    Annals of Clinical Microbiology and Antimicrobials, 8
  • [45] Bullous fixed drug eruption in a patient with metastatic renal cell carcinoma induced by iodinated contrast during pazopanib treatment
    Epskamp, Cynthia
    Snels, Dyon G. C. T. M.
    Yo, Glenn L.
    Zuetenhorst, Hanneke J. M.
    Hamberg, Paul
    EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (02) : 207 - 208
  • [46] Bullous fixed drug eruption in a patient with metastatic renal cell carcinoma induced by iodinated contrast during pazopanib treatment
    Cynthia Epskamp
    Dyon G.C.T.M. Snels
    Glenn L. Yo
    Hanneke J.M. Zuetenhorst
    Paul Hamberg
    European Journal of Dermatology, 2016, 26 : 207 - 208
  • [47] Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report
    Mendiola, Vincent Louie
    Kesireddy, Meghana
    Jana, Bagi
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
  • [48] Effect of rechallenge nivolumab in a hemodialysis patient with multiple metastases from a rapidly progressed T1a renal clear cell carcinoma: An autopsy case
    Hanawa, Kazushi
    Sawada, Norifumi
    Yokota, Yuka
    Aikawa, Junki
    Otake, Yuko
    Sugimura, Koki
    Shimura, Hiroshi
    Mochizuki, Takanori
    Kira, Satoru
    Mitsui, Takahiko
    IJU CASE REPORTS, 2024, 7 (03) : 202 - 205
  • [49] Disseminated intravascular coagulation induced by pazopanib following combination therapy of nivolumab plus ipilimumab in a patient with metastatic renal cell carcinoma
    Hashimoto, Mamoru
    Nakayama, Takahito
    Fujimoto, Saizo
    Inoguchi, Shunsuke
    Nishimoto, Mitsuhisa
    Kikuchi, Takashi
    Adomi, Shogo
    Banno, Eri
    De Velasco, Marco A.
    Saito, Yoshitaka
    Shimizu, Nobutaka
    Mori, Yasunori
    Minami, Takafumi
    Fujita, Kazutoshi
    Nozawa, Masahiro
    Nose, Kazuhiro
    Yoshimura, Kazuhiro
    Uemura, Hirotsugu
    ANTI-CANCER DRUGS, 2022, 33 (01) : E818 - E821
  • [50] Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient
    Catalano, Fabio
    Rebuzzi, Sara Elena
    Murianni, Veronica
    Damassi, Alessandra
    Martelli, Valentino
    Borea, Roberto
    Rollandi, Gian Andrea
    Fornarini, Giuseppe
    ANTI-CANCER DRUGS, 2022, 33 (01) : E724 - E729